Literature DB >> 11279663

Refractory autoimmune thrombocytopenic purpura treatment with Rituximab.

K Patel, J Berman, A Ferber, J Caro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11279663     DOI： 10.1002/ajh.1081

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

Review 1.  Treating human autoimmune disease by depleting B cells.

Authors:  R J Looney
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

Review 2.  Refractory idiopathic immune thrombocytopenic purpura in children: current and future treatment options.

Authors:  Paul Imbach
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

3.  CD72 polymorphism associated with child-onset of idiopathic thrombocytopenic purpura in Chinese patients.

Authors:  Jianhui Xu; Shihong Lu; Jie Tao; Zeping Zhou; Zhenping Chen; Ying Huang; Renchi Yang
Journal:  J Clin Immunol       Date:  2008-05       Impact factor: 8.317

4.  B cells as a therapeutic target in autoimmune disease.

Authors:  Jörg J Goronzy; Cornelia M Weyand
Journal:  Arthritis Res Ther       Date:  2003-03-19       Impact factor: 5.156
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.